Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabien Tech. Regulatory News (SNT)

Share Price Information for Sabien Tech. (SNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.50
Bid: 12.00
Ask: 13.00
Change: 0.00 (0.00%)
Spread: 1.00 (8.333%)
Open: 12.50
High: 12.50
Low: 12.50
Prev. Close: 12.50
SNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Placing

13 May 2019 07:00

RNS Number : 7437Y
Sabien Technology Group PLC
13 May 2019
 

For immediate release

13 May 2019

 

Sabien Technology Group plc

 ("Sabien" or the "Company")

Placing

 

The Board of Sabien announces that the Company's broker, Peterhouse Capital Limited ("Peterhouse"), has today raised gross proceeds of £300,000 via the placing of 300,000,000 new ordinary shares (the "Placing Shares") with new and existing investors, at a price of 0.1 pence per Placing Share (the "Placing Price") pursuant to the Company's existing share authorities. The Placing is conditional on admission of the Placing Shares to trading on AIM. Following completion of the Placing, the enlarged issued share capital of the Company comprises 890,254,867 New Ordinary Shares of 0.01 pence each. Once issued, the Placing shares will rank pari passu with the Company's existing ordinary shares. Application will be made for the Placing Shares to be admitted to trading on AIM ("Admission") which is expected to become effective on or around 17 May 2019.

 

The proceeds of the Placing will be used to provide additional working capital for the Company and in particular, to finance in the short term, the delivery of the current sales order announced in April this year, and more generally to support sales activities to generate further orders from the sales pipeline outlined in the interim results published on 14 February 2019 and to allow the Board the ability to continue to evaluate additional acquisition and investment opportunities to enhance the long-term value of the Company for shareholders.

 

The Board continues to be very aware that any Placing is dilutive for the existing shareholders and considered whether any pre-emptive offering might be possible, but concluded that it was neither practicable nor cost effective to do so at this time, particularly given current uncertain market conditions and the working capital requirements of the Company. The Board has therefore sought to minimise the impact of dilution on existing shareholders by raising the minimum funding necessary to meet its current and projected needs and by seeking to minimise the discount of the Placing Price to the current market price. Overall, the Placing Price represents a discount of approximately 26% percent to the closing mid-market price of 0.135p per share on 10 May 2019, the last practicable date before proceeding with the Placing. The Placing Shares will represent approximately 33.7% of the enlarged share capital of the Company.

 

Pursuant to the Placing arranged by Peterhouse, Hawk Investments Holdings Limited ("HIHL"), has subscribed for 68,544,000 Placing Shares. HIHL is an existing shareholder interested in 22.85% of the current issued share capital of the Company and its subscription therefore is treated as a related party transaction for the purposes of the AIM Rules. HIHL has subscribed on the same terms and conditions as the other Placees, which have been procured on an arms-length basis by the Company's broker, Peterhouse. The Directors consider, having consulted with the Company's Nominated Adviser, that the terms of HIHL's subscription pursuant to the Placing are fair and reasonable insofar as all shareholders are concerned.

 

Total Voting Rights

In conformity with the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority ("FCA"), with effect from 17 May 2019, the Company's issued share capital consists of 890,254,867 Ordinary Shares of 0.01p each with voting rights. The Company does not hold any Ordinary Shares in Treasury. Therefore, the total number of Ordinary Shares in the Company with voting rights is 890,254,867.

 

The above figure of 890,254,867 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Special note concerning the Market Abuse Regulation

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014 ("MAR"). Market soundings, as defined in MAR, were taken in respect of the Placing, with the result that certain persons became aware of inside information, as permitted by MAR. That inside information is set out in this announcement. Therefore, those persons that received inside information in a market sounding are no longer in possession of inside information relating to the Company and its securities.

 

The person who arranged for the release of this announcement on behalf of the Company was Alan O'Brien, CEO and Director.

 

For further information:

 

Sabien Technology Group plc

Alan O'Brien

+44(0)20 7993 3700

Beaumont Cornish Limited (Nominated Advisor)

Michael Cornish and Roland Cornish

www.beaumontcornish.com

+44(0)20 7628 3396

Peterhouse Capital Limited (Broker)

Duncan Vasey and Martin Lampshire

+44(0)20 7469 0930

 

 

 

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEVLLFFKEFBBBE
Date   Source Headline
26th Mar 20137:00 amRNSFireye Distributorship Agreement
12th Feb 20139:29 amRNSHolding(s) in Company
12th Feb 20137:00 amRNSHalf Yearly Report
6th Feb 20133:44 pmRNSHolding(s) in Company
6th Feb 20133:11 pmRNSChange of ACD for OEIC holding
31st Jan 201310:11 amRNSNotice of Results
22nd Nov 20127:00 amRNSAGM Statement
30th Oct 201210:44 amRNSGrant of share options
29th Oct 201210:19 amRNSDispatch of Annual Financial Report
17th Oct 20127:00 amRNSAppointment of Mrs Miriam Maes as a Director
1st Oct 20127:00 amRNSPreliminary Statement of Final Results
30th Aug 20122:30 pmRNSRetirement of Chairman
10th Jul 20127:00 amRNSPost Close Trading Statement
7th Mar 20127:00 amRNSRe Contract
7th Feb 20127:00 amRNSHalf Yearly Report
1st Feb 20127:00 amRNSRe-organisation of Nominated Adviser and Broker
12th Jan 201212:20 pmRNSDirector Declaration
12th Jan 20129:27 amRNSCapital Reorganisation
9th Jan 20127:00 amRNSNotice of Results
5th Jan 20127:00 amRNSChange of Adviser
19th Dec 201110:54 amRNSDirector Declaration
29th Nov 201110:19 amRNSHolding(s) in Company
24th Nov 20117:00 amRNSResult of AGM
21st Nov 201110:26 amRNSHolding(s) in Company
17th Nov 201111:23 amRNSHolding(s) in Company
4th Nov 20111:50 pmRNSHolding(s) in Company
1st Nov 20117:00 amRNSAnnual Report and Accounts
7th Oct 20117:00 amRNSNew Contract Win
3rd Oct 20117:00 amRNSFinal Results
12th Sep 20117:00 amRNSNew Contract Win
25th Aug 20117:00 amRNSNew Contract Win
11th Jul 20117:00 amRNSPost Year End Trading Update
29th Jun 20111:12 pmRNSM2G sale to US Distributor
2nd Jun 201112:15 pmRNSNotice of Results
8th Apr 201111:28 amRNSM2G sale to US Distributor
2nd Mar 201111:44 amRNSHolding(s) in Company
1st Mar 201111:08 amRNSHolding(s) in Company
7th Feb 20117:00 amRNSHalf Yearly Report
5th Jan 20117:00 amRNSNotice of Results and Trading Update
26th Nov 20107:00 amRNSDirector/PDMR Shareholding
25th Nov 20107:00 amRNSResult of AGM
17th Nov 20107:00 amRNSAward of Contract
12th Nov 20104:12 pmRNSAnnual Financial Report
29th Oct 20107:00 amRNSPreliminary Results
18th Oct 20107:00 amRNSNotice of Results
15th Oct 20107:00 amRNSDirectorate Change
20th Sep 20107:00 amRNSAward of Contract
6th Aug 20107:00 amRNSAward of Contract
5th Jul 20107:00 amRNSAward of Contract
24th Jun 20107:00 amRNSAward of Contract

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.